Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms-Reference-Cited by-同舟云学术

Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms

Published:2021-11 Issue: Volume: Page:
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Zhang Shutao,Qu Xinhua,Jiao Juyang,Tang Haozheng,Wang Minqi,Wang You,Yang Hongtao,Yuan Weien,Yue Bing^ORCID

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference54 articles.

1. I. Emerging infections Program healthcare-associated, T. Antimicrobial use prevalence survey, multistate point-prevalence survey of health care-associated infections;Magill;N. Engl. J. Med.,2014

2. Treatment of infections associated with surgical implants;Darouiche;N. Engl. J. Med.,2004

3. Understanding biofilm resistance to antibacterial agents;Davies;Nat. Rev. Drug Discov.,2003

4. Periprosthetic joint infection: the incidence, timing, and predisposing factors;Pulido;Clin. Orthop. Relat. Res.,2008

5. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research;Turner;Nat. Rev. Microbiol.,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of biofilm in extended-spectrum beta-lactamase Staphylococcus aureus with drugs commonly used in pharmacotherapy;Microbial Pathogenesis;2024-10

2. Infection microenvironment-triggered nanoparticles eradicate MRSA by thermally amplified chemodynamic therapy and M1 macrophage;Journal of Nanobiotechnology;2024-07-30

3. Pheromone cCF10 inhibits the antibiotic persistence of Enterococcus faecalis by modulating energy metabolism;Frontiers in Microbiology;2024-07-08

4. Exciting Bacteria to a Hypersensitive State for Enhanced Aminoglycoside Therapy by a Rationally Constructed AIE Luminogen;Advanced Healthcare Materials;2024-05-27

5. Lusutrombopag as a Repurposing Drug in Combination with Aminoglycosides against Vancomycin-Resistant Enterococcus;ACS Infectious Diseases;2024-04-03